Scientists test custom cancer vaccine made from Patient's own tumor
NCT ID NCT01753089
Summary
This early-stage study tested a new, personalized vaccine for people with advanced melanoma that had spread. Doctors created the vaccine for each patient using proteins from their own tumor cells, combined with immune-boosting agents, and placed it under the skin in a small, dissolvable tablet. The main goals were to see if the vaccine could be made safely, to check for side effects, and to learn if it could trigger the patient's immune system to attack their cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02215, United States
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
Conditions
Explore the condition pages connected to this study.